Poonam Laxmappa Hosamani

Poonam Hosamani practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Poonam Hosamani's NPI, 1609018662, was assigned on April 6, 2009. Poonam Hosamani holds California license A121030.

Poonam Hosamani's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Poonam Hosamani's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Poonam Hosamani to 1 more hospital and 1 medical group, each named with a free account. Poonam Hosamani's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Poonam Hosamani practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Poonam Hosamani's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Poonam Hosamani is licensed in California.

CMS data shows 435 Medicare services from Poonam Hosamani across 4 procedure codes in 2024, for 131 Medicare patients. Medicare paid $48,999 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 131 Medicare patients who saw Poonam Hosamani in 2024. The largest group is 75 to 84, with 48 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 54% are also on Medicaid. Their average risk score is 2.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Poonam Hosamani's median patient age at 56, with 46% women.

In 2024, Poonam Hosamani wrote 83 Medicare Part D claims for 27 patients. 84% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $6,666 in total drug cost. In 2020, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Poonam Hosamani for performance year 2024, reported as part of a group. Poonam Hosamani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Poonam Hosamani from 1 drug or device company in 2017. Consulting fees make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $750.